Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.43)
# 975
Out of 4,734 analysts
428
Total ratings
36.47%
Success rate
7.76%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Reiterates: Buy | $36 | $7.37 | +388.47% | 8 | Jan 15, 2025 | |
| CDNA CareDx | Reiterates: Neutral | $26 | $21.44 | +21.27% | 10 | Jan 14, 2025 | |
| BRNS Barinthus Biotherapeutics | Maintains: Buy | $5 → $3 | $1.04 | +188.46% | 12 | Jan 13, 2025 | |
| ANGO AngioDynamics | Maintains: Buy | $14 → $15 | $12.43 | +20.68% | 9 | Jan 10, 2025 | |
| OPK OPKO Health | Maintains: Buy | $3 | $1.47 | +104.08% | 10 | Jan 8, 2025 | |
| OCS Oculis Holding AG | Reiterates: Buy | $30 | $22.74 | +31.93% | 12 | Jan 6, 2025 | |
| VERU Veru Inc. | Reiterates: Buy | $3 | $0.98 | +207.57% | 20 | Jan 2, 2025 | |
| SMTI Sanara MedTech | Initiates: Buy | $50 | $32.64 | +53.19% | 1 | Dec 23, 2024 | |
| BLCO Bausch + Lomb | Reiterates: Buy | $23 | $17.36 | +32.49% | 15 | Dec 12, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | $49 | $18.00 | +172.22% | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $7.68 | +121.35% | 20 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.48 | +194.12% | 20 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $8.01 | +87.27% | 25 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.90 | +426.32% | 4 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.22 | +104.92% | 19 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.83 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.91 | +130.18% | 16 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.41 | +190.46% | 17 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $6.56 | +67.68% | 17 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $7.25 | +106.90% | 19 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $5.28 | +165.15% | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.93 | +545.23% | 18 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $100 | $56.21 | +77.90% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.91 | +155.75% | 15 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.90 | +144.90% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1.5 | $0.80 | +88.68% | 22 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.20 | +150.00% | 1 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.04 | +573.08% | 9 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $12.87 | +195.26% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $1.5 | $0.19 | +683.70% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.72 | +1,288.89% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.60 | +1,747.81% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.30 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $0.82 | +21,851.22% | 1 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $18.77 | +155.73% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.06 | +12,679.55% | 5 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $10.93 | +73.83% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.28 | - | 2 | Apr 16, 2020 |
REGENXBIO
Jan 15, 2025
Reiterates: Buy
Price Target: $36
Current: $7.37
Upside: +388.47%
CareDx
Jan 14, 2025
Reiterates: Neutral
Price Target: $26
Current: $21.44
Upside: +21.27%
Barinthus Biotherapeutics
Jan 13, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $1.04
Upside: +188.46%
AngioDynamics
Jan 10, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $12.43
Upside: +20.68%
OPKO Health
Jan 8, 2025
Maintains: Buy
Price Target: $3
Current: $1.47
Upside: +104.08%
Oculis Holding AG
Jan 6, 2025
Reiterates: Buy
Price Target: $30
Current: $22.74
Upside: +31.93%
Veru Inc.
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.98
Upside: +207.57%
Sanara MedTech
Dec 23, 2024
Initiates: Buy
Price Target: $50
Current: $32.64
Upside: +53.19%
Bausch + Lomb
Dec 12, 2024
Reiterates: Buy
Price Target: $23
Current: $17.36
Upside: +32.49%
Tourmaline Bio
Dec 11, 2024
Reiterates: Buy
Price Target: $49
Current: $18.00
Upside: +172.22%
Dec 6, 2024
Reiterates: Buy
Price Target: $17
Current: $7.68
Upside: +121.35%
Dec 5, 2024
Reiterates: Buy
Price Target: $22
Current: $7.48
Upside: +194.12%
Dec 3, 2024
Reiterates: Buy
Price Target: $15
Current: $8.01
Upside: +87.27%
Dec 2, 2024
Reiterates: Buy
Price Target: $10
Current: $1.90
Upside: +426.32%
Nov 27, 2024
Reiterates: Buy
Price Target: $2.5
Current: $1.22
Upside: +104.92%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.83
Upside: -
Nov 22, 2024
Reiterates: Buy
Price Target: $9
Current: $3.91
Upside: +130.18%
Nov 19, 2024
Reiterates: Buy
Price Target: $7
Current: $2.41
Upside: +190.46%
Nov 18, 2024
Maintains: Buy
Price Target: $10 → $11
Current: $6.56
Upside: +67.68%
Nov 15, 2024
Reiterates: Buy
Price Target: $15
Current: $7.25
Upside: +106.90%
Nov 15, 2024
Reiterates: Buy
Price Target: $14
Current: $5.28
Upside: +165.15%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.93
Upside: +545.23%
Nov 13, 2024
Maintains: Buy
Price Target: $60 → $100
Current: $56.21
Upside: +77.90%
Nov 12, 2024
Reiterates: Buy
Price Target: $10
Current: $3.91
Upside: +155.75%
Nov 11, 2024
Reiterates: Buy
Price Target: $12
Current: $4.90
Upside: +144.90%
Nov 11, 2024
Reiterates: Neutral
Price Target: $1.5
Current: $0.80
Upside: +88.68%
Nov 7, 2024
Initiates: Buy
Price Target: $3
Current: $1.20
Upside: +150.00%
Oct 24, 2024
Reiterates: Buy
Price Target: $7
Current: $1.04
Upside: +573.08%
Aug 23, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $12.87
Upside: +195.26%
Jun 10, 2024
Maintains: Buy
Price Target: $7 → $1.5
Current: $0.19
Upside: +683.70%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.72
Upside: +1,288.89%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.60
Upside: +1,747.81%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.30
Upside: -
May 19, 2022
Maintains: Buy
Price Target: $240 → $180
Current: $0.82
Upside: +21,851.22%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $18.77
Upside: +155.73%
Apr 1, 2021
Maintains: Buy
Price Target: $6 → $8
Current: $0.06
Upside: +12,679.55%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $10.93
Upside: +73.83%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.28
Upside: -